cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution

Autor: Li, Shuo, Zeng, Weihua, Ni, Xiaohui, Zhou, Yonggang, Stackpole, Mary L, Noor, Zorawar S, Yuan, Zuyang, Neal, Adam, Memarzadeh, Sanaz, Garon, Edward B, Dubinett, Steven M, Li, Wenyuan, Zhou, Xianghong Jasmine

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 9

PurposeCell-free DNA (cfDNA) offers a noninvasive approach to monitor cancer. Here we develop a method using whole-exome sequencing (WES) of cfDNA for simultaneously monitoring the full spectrum of cancer treatment outcomes, including minimal residua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::ea99106aaf1e296857420e94f99be33c
https://escholarship.org/uc/item/9mt8g3fx

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC).

Autor: Noor, Zorawar S., Master, Aashini

Publikováno v: Current Breast Cancer Reports; Dec2018, Vol. 10 Issue 4, p282-288, 7p

cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution.

Autor: Li S; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.; Bioinformatics Interdepartmental Graduate Program, University of California at Los Angeles, Los Angeles, California.; EarlyDiagnostics Inc., Los Angeles, California., Zeng W; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California., Ni X; EarlyDiagnostics Inc., Los Angeles, California., Zhou Y; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California., Stackpole ML; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.; Bioinformatics Interdepartmental Graduate Program, University of California at Los Angeles, Los Angeles, California.; EarlyDiagnostics Inc., Los Angeles, California., Noor ZS; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Yuan Z; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California., Neal A; Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California.; UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California., Memarzadeh S; Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California.; UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California.; UCLA Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.; Molecular Biology Institute, University of California Los Angeles, Los Angeles, California.; VA Greater Los Angeles Health Care System, Los Angeles, California., Garon EB; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California., Dubinett SM; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.; VA Greater Los Angeles Health Care System, Los Angeles, California.; Department of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Microbiology, Immunology and Molecular Genetics, University of California at Los Angeles, Los Angeles, California., Li W; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California., Zhou XJ; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 02; Vol. 28 (9), pp. 1841-1853.